Toronto-based Cameron Clokie Pioneers Regenerative Tissue Development Therapy

A sexagenarian is expected to have a wrinkled face, but this is not the case for Peter Russel, a dedicated farmer who is also a golf hobbyist. Unlike other men of his generation, Peter still has a defined, chiseled jawline characterized with young people.

Even more fascinating, Peter grew the jowl himself about two years ago. It may sound inconceivable, but Peter’s jaw bone has regenerated, increasing by seven centimeters to restore a tissue removed as a result of the presence of a benign tumor.

Peter had the honor of being one of the pioneering clients to receive the trailblazing bone regeneration procedure. This discovery is projected to transform the reconstructive surgery landscape within the next few years. The program is directed by Cameron Clokie, head of the oral surgery department at the University of Toronto.

It entails the use of proteins to stimulate the adult stem cells to produce bone tissues. This procedure was inspired by the bone formation process in newborns and has since been engineered to regenerate jawbones.

Expounding on the subject, Cameron said that it borrows from the embryonic stage of bone formation. He added the results were spectacular, with the regenerated jawbones integrating seamlessly due to being identical.

As of now, the therapy is performed at the Toronto General Hospital as well as Mount Sinai Hospital. Though still in early stages, it has opened up a world of new possibilities, particularly on the subject of regenerative tissue development, which was hitherto implausible.

The procedures that are currently in use are painful and intolerable, as they involve the removal of grafts from one body part and implanting them on the affected part.

As expected of any new therapy, the tissue regeneration remedy has been met with some challenging cases. Not all patients have responded promptly to the procedure, with some cases taking longer than usual to heal. This, however, has not distracted the experts, as they continue to search for ways to better the medication.

Perhaps the most overwhelming challenge is the cost of the operation. The morphogenetic protein, which is fundamental to induce regeneration, costs well over $6,000. To make matter worse, the cost is not covered by insurance. Despite these obstacles, patients are embracing the technology as it is way better than the traditional methods.

Click on the links to read more:

Dr. Cameron Clokie – Hospital Information and Nearby Florists
Cameron Clokie Speaks to Regenerative Medicine